Lexeo Therapeutics, Inc. · NASDAQ:LXEO
Vestal Point Capital, LP reported a 7.50% stake in Lexeo Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Vestal Point Capital, LP reported a 7.50% stake in Lexeo Therapeutics, Inc., 4,117,302 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 7.50%
- Shares
- 4,117,302
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vestal Point Capital, LP | 7.50% | 4,117,302 |
| Ryan Wilder | 7.50% | 4,117,302 |
Source
Related
- Lexeo Therapeutics, Inc.
- Vestal Point Capital, LP
- Lexeo Therapeutics, Inc. shareholders
- Schedule 13G · Vestal Point Capital, LP · Aug 14, 2025
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Bhalla Narinder Pal · Sep 28, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Tamayo Louis Edward · Aug 19, 2026